Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H)

European Journal of Haematology

Volumn 72, Issue 1, 2004, Pages 61-63

  Gautschi, O ^a   Blumenthal, N ^a   Streit, M ^b   Solenthaler, M ^a   Hunziker, T ^b   Zenhausern R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Klinik und Poliklinik fur Dermatologie   (Switzerland)

Author keywords

Campath 1H; Cutaneous T cell lymphoma; Monoclonal antibodies; S zary syndrome

Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MONOCLONAL ANTIBODY; NAVELBINE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; ADVANCED CANCER; ANAMNESIS; ARTICLE; BLOOD EXAMINATION; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG APPROVAL; DRUG EFFICACY; DRUG POTENCY; FOLLOW UP; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; PUVA; SEZARY SYNDROME; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG RESISTANCE; HODGKIN DISEASE; HUMANS; MALE; NEOPLASMS, SECOND PRIMARY; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 0742269482     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-4441.2004.00169.x     Document Type: Article

References (7)

1. SIEGEL RS, PANDOLFINO T, GUITART J, ROSEN S, KUZEL TM. Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 2000;18:2908-2925.
2. HERNE KL, TALPUR R, BREUER-MCHAM J, CHAMPLIN R, DUVIC M. Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sezary syndrome. Blood 2003;101:2132-2136.
3. APISARNTHANARAX N, TALPUR R, DUVIC M. Treatment of cutaneous T cell lymphoma: current status and future directions. Am J Clin Dermatol 2002;3:193-215.
4. HALE G, XIA MQ, TIGHE HP, DYER MJ, WALDMANN H. The Campath-1 antigen (CDw52). Tissue Antigens 1990;35:118-127.
5. HALE G, SWIRSKY D, WALDMANN H, CHAN LC. Reactivity of rat monoclonal antibody Campath-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation. Br J Haematol 1985;60:41-48.
6. FLYNN JM, BYRD JC. Campath-1H monoclonal antibody therapy. Curr Opin Oncol 2000;12:574-581.
7. LUNDIN J, HAGBERG H, REPP R, CAVALLIN-STAHL E, FREDEN S, JULIUSSON G, ROSENBLAD E, TJONNFJORD G, WIKLUND T, OSTERBORG A. Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome. Blood 2003;101:4267-4272.